Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) Receivables Turnover : 0.00 (As of Dec. 2014)

View and export this data going back to 2007. Start your Free Trial

What is Omni Bio Pharmaceutical Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Omni Bio Pharmaceutical's Revenue for the three months ended in Dec. 2014 was $0.00 Mil. Omni Bio Pharmaceutical's average Accounts Receivable for the three months ended in Dec. 2014 was $0.00 Mil.

Omni Bio Pharmaceutical Receivables Turnover Historical Data

The historical data trend for Omni Bio Pharmaceutical's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omni Bio Pharmaceutical Receivables Turnover Chart

Omni Bio Pharmaceutical Annual Data

Trend

Dec06

Dec07

Dec08

Mar09

Mar10

Mar11

Mar12

Mar13

Mar14

Receivables Turnover

Get a 7-Day Free Trial

Omni Bio Pharmaceutical Quarterly Data
	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14
Receivables Turnover	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Omni Bio Pharmaceutical's Receivables Turnover

For the Biotechnology subindustry, Omni Bio Pharmaceutical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Omni Bio Pharmaceutical's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Omni Bio Pharmaceutical's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Omni Bio Pharmaceutical's Receivables Turnover falls into.

Omni Bio Pharmaceutical Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Omni Bio Pharmaceutical's Receivables Turnover for the fiscal year that ended in Mar. 2014 is calculated as

	Receivables Turnover (A: Mar. 2014 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Mar. 2014 )	/ (	(Accounts Receivable (A: Mar. 2013 )	+	Accounts Receivable (A: Mar. 2014 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Omni Bio Pharmaceutical's Receivables Turnover for the quarter that ended in Dec. 2014 is calculated as

	Receivables Turnover (Q: Dec. 2014 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2014 )	/ (	(Accounts Receivable (Q: Sep. 2014 )	+	Accounts Receivable (Q: Dec. 2014 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Omni Bio Pharmaceutical (GREY:OMBP) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Omni Bio Pharmaceutical Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Omni Bio Pharmaceutical's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omni Bio Pharmaceutical Inc (GREY:OMBP) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

5350 South Roslyn, Suite 430, Greenwood Village, CO, USA, 80111

Website

http://www.omnibiopharma.com

Omni Bio Pharmaceutical Inc is a US-based biopharmaceutical company, which is engaged in the exploration of new methods of use of alpha-1 antitrypsin (AAT). It offers AAT, a naturally occurring protein that is essential for normal liver and lung function and has been purified from human blood to treat patients suffering from emphysema due to AAT-deficiency. Further, it focuses on the research and development efforts of advancing its first recombinant molecule, AAT and an Fc component of immunoglobulin (AAT-Fc 2) into clinical trials. Geographically these activities are functioned through the region of US.

Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) Headlines

No Headlines